Rhodiola (Rhodiola spp.): An evidence-based systematic review by the natural standard research collaboration

Alternative and Complementary Therapies

Volumn 17, Issue 2, 2011, Pages 110-119

  Ulbricht, Catherine ^a,b   Chao, Wendy ^a   Tanguay Colucci, Shaina ^a   Conquer, Julie ^c   Costa, Dawn ^a   Culwell, Samantha ^a   Giese, Nicole ^a   Higdon, Elizabeth R B ^a   Isaac, Richard ^a   Kaltenbach, Melissa ^a   Kligler, Benjamin ^d   Laster, Rachel ^a   Liu, Yanze ^e   McCarthy, Mary ^a   Nachum, Benjamin ^a   Nummy, Katie ^a   Redwanski, John ^f   Rusie, Erica ^a   Windsor, Regina ^a   Wojcik, Gregory J ^g   Zhou, Sara ^a   more..

^a Natural Standard   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c RGB Consulting   (Canada)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e MCLEAN HOSPITAL   (United States)

^f UNIVERSITY OF NEW ENGLAND   (United States)

^g VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955854624     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.2011.17208     Document Type: Review

References (60)

1. De Sanctis R, De Bellis R, Scesa C, et al. In vitro protective effect of Rhodiola rosea extract against hypochlorous acid-induced oxidative damage in human erythrocytes. Biofactors 2004;20:147-159. (Pubitemid 40164152)
2. Zong Y, Lowell K, Ping JA, et al. Phenolic constituents of Rhodiola coccinea, a Tibetan folk medicine. Planta Med 1991;57:589.
3. Darbinyan V, Kteyan A, Panossian A, et al. Rhodiola rosea in stress induced fatigue-a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000;7:365-371.
4. Shevtsov VA, Zholus BI, Shervarly VI, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003;10(2-3):95-105. (Pubitemid 36433202)
5. Kim SH, Hyun SH, Choung SY. Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice. Biofactors 2006;26:209-219.
6. Kwon YI, Jang HD, Shetty K. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension. Asia Pac J Clin Nutr 2006;15:425-432. (Pubitemid 44423425)
7. McGovern E, McDonnell TJ. Herbal medicine-sets the heart racing! Ir Med J 2010;103:219.
8. Zhang ZH, Liu JS, Chu JN, et al. The effect of Hongjingtian (gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs [in Chinese]. Zhongguo Zhong Yao Za Zhi 2005;30:1001-1005.
9. Maimeskulova LA, Maslov LN. Anti-arrhythmic effect of phytoadaptogens [in Russian]. Eksp Klin Farmakol 2000;63:29-31.
10. Maimeskulova LA, Maslov LN, Lishmanov IuB, Krasnov EA. The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea [in Russian]. Eksp Klin Farmakol 1997;60:38-39.
11. Lishmanov IuB, Maslova LV, Maslov LN, Dan'shina EN. The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism [in Russian]. Biull Eksp Biol Med 1993;116:175-176. (Pubitemid 24017441)
12. Lishmanov, IuB, Naumova, AV, Afanas'ev SA, Maslov LN. Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro [in Russian]. Eksp Klin Farmakol 1997;60:34-36.
13. Maimeskulova LA, Maslov LN. The anti-arrhythmia action of an extract of Rhodiola rosea and of N-tyrosol in models of experimental arrhythmias [in Russian]. Eksp Klin Farmakol 1998;61:37-40.
14. Hellum BH, Tosse A, Hoybakk K, et al. Potent in vitro inhibition of CYP3A4 and p-glycoprotein by Rhodiola rosea. Planta Med 2010;76:331-338.
15. Scott IM, Leduc RI, Burt AJ, et al. The inhibition of human cytochrome p450 by ethanol extracts of North American botanicals. Pharmaceutical Biol (Netherlands) 2006;44:315-327. (Pubitemid 43995602)
16. Panossian A, Nikoyan N, Ohanyan N, et al. Comparative study of Rhodiola preparations on behavioral despair of rats. Phytomedicine 2008;15 (1-2):84-91.
17. Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human p-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;302:645-650. (Pubitemid 34787231)
18. Kelly GS. Rhodiola rosea: A possible plant adaptogen. Altern Med Rev 2001;6:293-302. (Pubitemid 32591865)
19. Li T, Xu G, Wu L, Sun C. Pharmacological studies on the sedative and hypnotic effect of salidroside from the Chinese medicinal plant Rhodiola sachalinensis. Phytomedicine 2007;14:601-604. (Pubitemid 47176409)
20. Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res 2006;20:424-425.
21. Bocharova OA, Matveev BP, Baryshnikov AI, et al. The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research) [in Russian]. Urol Nefrol (Mosk) 1995;2: 46-47.
22. Mishra KP, Chanda S, Shukla K, Ganju L. Adjuvant effect of aqueous extract of Rhodiola imbricata rhizome on the immune responses to tetanus toxoid and ovalbumin in rats. Immunopharmacol Immunotoxicol 2010;32:141-146.
23. Li HX, Sze SC, Tong Y, Ng TB. Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb, Rhodiola algida, on human peripheral blood monocytes. J Ethnopharmacol 2009;123:257-266.
24. Mishra KP, Ganju L, Chanda S, et al. Aqueous extract of Rhodiola imbricata rhizome stimulates toll-like receptor 4, granzyme-B and Th1 cytokines in vitro. Immunobiology 2009;214:27-31.
25. Skopnska-Rozewska E, Wojcik R, Siwicki AK, et al. The Effect of Rhodiola quadrifida extracts on cellular immunity in mice and rats. Polish J Vet Sci 2008;11:105-111. (Pubitemid 351896343)
26. Panossian A, Hovhannisyan A, Abrahamyan H, et al. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats. Phytother Res 2009;23: 351-357.
27. Bawa AS, Khanum F. Anti-inflammatory activity of Rhodiola rosea-"a second-generation Adaptogen." Phytother Res 2009;23:1099-1102.
28. van Diermen D, Marston A, Bravo J, et al. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 2009;122:397-401.
29. Reviews of articles on medicinal herbs. Aust J Med Herbalism 2009; 21:49-51.
30. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010;17:481-493.
31. Kiefer D. Rhodiola rosea for general anxiety disorder. Alternat Med Alert 2008;11:61-65.
32. Zheng KY, Guo AJ, Bi CW, et al. The extract of Rhodiolae crenulatae Radix et rhizoma induces the accumulation of HIF-1alpha via blocking the degradation pathway in cultured kidney fibroblasts. Planta Med 2010;December 14:e-pub ahead of print.
33. Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: A systematic review of randomized clinical trials. Phytomedicine 2011;18:235-244.
34. Abidov M, Grachev S, Seifulla RD, Ziegenfuss TN. Extract of Rhodiola rosea radix reduces the level of C-reactive protein and creatinine kinase in the blood. Bull Exp Biol Med 2004;138:63-64. (Pubitemid 39485456)
35. De Bock K, Eijnde BO, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 2004;14:298-307. (Pubitemid 38821961)
36. Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo- controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000;7:85-89. (Pubitemid 30307605)
37. Spasov AA, Mandrikov VB, Mironova IA. The effect of the preparation Rodakson on the psychophysiological and physical adaptation of students to an academic load [in Russian]. Eksp Klin Farmakol 2000;63:76-78.
38. Walker TB, Altobelli SA, Caprihan A, Robergs RA. Failure of Rhodiola rosea to alter skeletal muscle phosphate kinetics in trained men. Metabolism 2007; 56:1111-1117. (Pubitemid 47021177)
39. Wing SL, Askew EW, Luetkemeier MJ, et al. Lack of effect of rhodiola or oxygenated water supplementation on hypoxemia and oxidative stress. Wilderness Environ Med 2003;14:9-16. (Pubitemid 36343254)
40. Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract Shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009;75:105-112.
41. Darbinyan V, Aslanyan G, Amroyan E, et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 2007;61:343-348. (Pubitemid 350091013)
42. Provino R. The role of adaptogens in stress management. Aust J Med Herbalism 2010;22:41-49.
43. Noreen E, Buckley J, Lewis S. The effects of an acute dose of Rhodiola rosea on exercise performance and cognitive function. J Int Soc Sports Nutr 2009;6(suppl1):1; online document at: www.jissn.com/content/6/S1/P14 Accessed April 6, 2011.
44. Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 2007;21:37-43. (Pubitemid 46173906)
45. Challem J. Rhodiola May Help Treat Anxiety. In: Medical journal watch: Context and applications. Altern Complement Ther 2008;14:220-221.
46. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 2008;14:175-180. (Pubitemid 351364412)
47. Zubeldia JM, Nabi HA, Del Rio MJ, Genovese J. Exploring new applications for Rhodiola rosea: Can we improve the quality of life of patients with short-term hypothyroidism induced by hormone withdrawal? J Med Food 2010;13:1287-1292.
48. Krasik ED, Morozova ES, Petrova KP et al. Therapy of asthenic conditions: Clinical perspectives of application of Rhodiola rosea extract (Golden Root). In: Proceedings of Modern Problems in Psycho-Pharmacology. Kemerovo-City, Russia: Siberian Branch of Russian Academy of Sciences 1970;298-330.
49. Brichenko VS, Kupriyanova IE, Skorokhova TF. The use of herbal adaptogens together with tricyclic antidepressants in patients with psychogenic depression. In: Modern Problems of Pharmacology and Search for New Medicines. Tomsk, Russia: Tomsk State University Press 1986;58-60; online document at: www.scicompdf.se/rosenrot/brichenko3.pdf Accessed April 6, 2010.
50. Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: Review and critique. J Affect Disord 2010;June 24:e-pub ahead of print.
51. Schulzz V. Rhodiola rosea radix extract for the treatment of mild to moderate depression? Results of a placebo-controlled clinical study. Komplement Integr Med Artztezeitschrift Naturheilverfahren 2009;3:36-41.
52. Schutgens FW, Neogi P, van Wijk EP, et al. The influence of adaptogens on ultraweak biophoton emission: A pilot experiment. Phytother Res 2009;23:1103-1108.
53. Petkov VD, Yonkov D, Mosharoff A, et al. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg 1986;12:3-16.
54. Qu ZQ, Zhou Y, Zeng YS, et al. Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: Implication of anti-oxidative and neuroprotective effects. Biomed Environ Sci 2009;22:318-326.
55. Saratikov AS, Krasnov EA, Chnikina LA, et al. Rhodiolosid, a new glycoside from Rhodiola rosea and its pharmacological properties [in German]. Pharmazie 1968;23:392-395.
56. Zotova MI. The effect of Rhodiola rosea extract on mental working activity in man. In: Collection of Reports at 3rd Scientific Conference of Physiologists, Biochemists and Pharmacologists of Western Siberia, Tomsk 1965;298- 299. Online document at: www.medref.se/rysk-rot/panossian-3.pdf Accessed April 7, 2011.
57. Blomkvist J, Taube A, Larhammar D. Perspective on roseroot (Rhodiola rosea) studies. Planta Med 2009;75:1187-1190.
58. Aslanyan G, Amroyan E, Gabrielyan E, et al. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine 2010;17:494-499.
59. Fintelmann V, Gruenwald J. Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Adv Ther 2007;24:929-939. (Pubitemid 351612266)
60. Narimanian M, Badalyan M, Panosyan V, et al. Impact of chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute nonspecific pneumonia. Phytomedicine 2005;12:723-729. (Pubitemid 41505328)